Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Faster, slicker, customisable & ad free!Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Go ad free today!Spring offer! Upgrade now at £2.99/m (40% OFF!)

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
Business
Football
Sport
Entertainment
Tech
Science

Biotech
Industry Sectors
Pharma
Biotechnology
FDA
Moderna
BioNTech
Genentech
Biogen
Amgen
GM Food
Illumina
Gilead Sciences
Celltrion
AbbVie
Regeneron
Topics

Advertisement

Biotech

Share

Top Latest Popular

⚽ PREMIER DEAL! Follow the action with NewsNow Essentials at just £2.99/m!

⚽ PREMIER DEAL! Follow the action with NewsNow Essentials at just £2.99 a month!

Gilead and Merck announce positive topline results from two Phase 3 studies evaluating islatravir/lenacapavir, an oral once-weekly HIV treatment Business Wire (Press Release) 12h

Business Wire (Press Release) 12h

Savara announces chief financial and administrative officer transition Business Wire (Press Release) 13h

Business Wire (Press Release) 13h

Spruce Biosciences announces long-term tralesinidase alfa enzyme Replacement therapy data in Sanfilippo Syndrome Type B (MPS IIIB) presented at the 18th International MPS Symposium Business Wire (Press Release) 13h

Business Wire (Press Release) 13h

Advertisement

STAT Plus: J&J spends $1 billion to enter KRAS race for cancer treatments STAT 19h

STAT 19h

Advertisement

Camargo v. AbbVie, Inc. U.S. Chamber of Commerce (Press Release) 19h

U.S. Chamber of Commerce (Press Release) 19h

STAT Plus: Novo underwhelmed by drug it once fought Pfizer for STAT 19h

STAT 19h

Advertisement

Advertisement

Latest

In the last half hour

Pharma in Spain: why global investors and innovators are moving in Labiotech 09:27

Eloxx Pharmaceuticals Prices $66 Million Offering And Uplisting To Nasdaq RTT News 09:23

In the last hour

UK pharma giant GSK to buy US-based cancer drugmaker Nuvalent for $10.6 billion Hindustan Times 08:45

In the last 2 hours

GSK Strikes $10.6B Nuvalent Deal Strengthening Targeting Cancer Pipeline RTT News 08:32

Pentixapharm Announces FDA Clearance of Ind for Phase 3 panda Study of First-in-Class Cardiovascular Diagnostic Program PR Newswire (Press Release) 08:14

STAT Plus: GSK to buy Nuvalent, maker of targeted cancer drugs, for $10.6B STAT 07:56

In the last 4 hours

US warns American businesses to cut ties with PLA-linked Chinese firms; adds Alibaba, BYD, NIO to 1260H List The Statesman 07:37

GSK in talks to buy cancer biotech Nuvalent for more than $9 billion The Hindu Business Line 07:15

In the last 6 hours

AprilBio to pitch REMAP platform at BIO 2026 as licensed assets show clinical progress Korea Biomedical Review 05:13

Hikma v. Amarin: It’s Not Just About Skinny Labels JD Supra 04:25

Advertisement

Advertisement

Advertisement

About our Biotech news

Latest Biotech news, covering the latest bioinformatics, bioengineering and more from the Biotechnology industry.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Biotech Biotech
Back to Industry Sectors Biotech
- GM Food GM Food
- AbbVie AbbVie
- Amgen Amgen
- Biogen Biogen
- BioNTech BioNTech
- Celltrion Celltrion
- Genentech Genentech
- Gilead Sciences
- Illumina Illumina
- Moderna Moderna